34 results
Keyword Scintimun Remove keyword
-
List item
Withdrawn application: Scintimun
besilesomab, date of withdrawal: 17/05/2006, Initial authorisation, Last updated: 22/05/2006Scintimun: Withdrawn application … Q&A SCINTIMUN Withdrawal European … MARKETING APPLICATION for SCINTIMUN International Non-proprietary … -
List item
Human medicine European public assessment report (EPAR): Scintimun
besilesomab, Osteomyelitis; Radionuclide Imaging
Date of authorisation: 11/01/2010, Revision: 6, Authorised, Last updated: 13/12/2022Scintimun Infections Bone Diseases … part of the EPAR). What is Scintimun? Scintimun is a kit for the preparation … substance besilesomab. What is Scintimun used for Scintimun is not used on its own, but … -
List item
Press release: CIS bio international withdraw their application for Scintimun
Last updated: 21/05/2006withdraw their application for Scintimun … for the medicinal product SCINTIMUN (besilesomab) 1 mg, kit for … marketing authorisation for SCINTIMUN to the EMEA on 3 February … -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 26-29 September 2022
European Medicines Agency, Amsterdam, the Netherlands, from 26/09/2022 to 29/09/2022, Last updated: 04/07/2022 -
List item
Committee for Medicinal Products for Human Use (CHMP): 10-13 October 2022
European Medicines Agency, Amsterdam, the Netherlands, from 10/10/2022 to 13/10/2022, Last updated: 23/11/2022 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 7-10 June 2022
European Medicines Agency, Amsterdam, the Netherlands, from 07/06/2022 to 10/06/2022, Last updated: 31/03/2022 -
List item
Committee for Medicinal Products for Human Use (CHMP): 19-22 April 2022
European Medicines Agency, Amsterdam, the Netherlands, from 19/04/2022 to 22/04/2022, Last updated: 12/08/2022 -
List item
Committee for Medicinal Products for Human Use (CHMP): 20-23 June 2022
European Medicines Agency, Amsterdam, the Netherlands, from 20/06/2022 to 23/06/2022, Last updated: 18/08/2022 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 8-11 July 2013
European Medicines Agency, London, UK, from 08/07/2013 to 11/07/2013, Last updated: 02/07/2012 -
List item
Fructose and sorbitol
Last updated: 09/10/2017 -
List item
PRAC: Agendas, minutes and highlights (updated)
Last updated: 25/09/2023 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 7-10 January 2013
European Medicines Agency, London, UK, from 07/01/2013 to 10/01/2013, Last updated: 02/06/2012 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 7-10 July 2014
European Medicines Agency, London, UK, from 07/07/2014 to 10/07/2014, Last updated: 13/08/2013 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 6-9 July 2015
European Medicines Agency, London, UK, from 06/07/2015 to 09/07/2015, Last updated: 13/03/2014 -
List item
Press release: Meeting highlights from the Committee for Medicinal Products for Human Use,19-22 October 2009
CHMP, Last updated: 23/10/2009following new medicines: Scintimun (besilesomab), from CIS bio … osteomyelitis. The review of Scintimun began on 23 July 2008, with … -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 26-29 September 2022
PRAC, Last updated: 30/09/2022 -
List item
Management Board meeting: 17-18 March 2010
European Medicines Agency, London, UK, from 17/03/2010 to 18/03/2010, Last updated: 01/09/2011 -
List item
CHMP: Agendas, minutes and highlights (updated)
Last updated: 11/09/2023 -
List item
Download medicine data
Last updated: 02/12/2021 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 7-10 June 2022
PRAC, Last updated: 10/06/2022 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 29 August-1 September 2017
European Medicines Agency, London, UK, from 29/08/2017 to 01/09/2017, Last updated: 13/03/2014 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 30 August - 2 September 2016
European Medicines Agency, London, UK, from 30/08/2016 to 02/09/2016, Last updated: 13/03/2014 -
List item
Committee for Medicinal Products for Human Use (CHMP): 18-21 January 2010
European Medicines Agency, London, UK, from 18/01/2010 to 21/01/2010, Last updated: 15/02/2010 -
List item
PRAC: Committee agendas, minutes and meeting highlights report archive 2012-2013
Last updated: 01/01/2015 -
List item
PRAC: meeting archive 2012-2014
Last updated: 13/05/2016